Step 1: Select the episodes & 1-minute challenges you'd like to consume
Step 2: Bank time as you blaze your way through the program
Step 3: Claim credit once available as shown in the Progress Bar
Step 4: Track the status of credits claimed in your profile
To experience MinuteCE for yourself, select one of the episodes below to start learning!
Challenges of Integrating Cognitive Remediation in CIAS
Challenges of Integrating Cognitive Remediation in CIAS
Understanding CIAS: What Does Current Literature Say About the Etiology and Pathophysiology of CIAS?
Understanding CIAS: What Does Current Literature Say About the Etiology and Pathophysiology of CIAS?
Integration Is the Key to Success: How Will the New SCZ Therapies Fit Into Clinical Treatment Paradigms?
Integration Is the Key to Success: How Will the New SCZ Therapies Fit Into Clinical Treatment Paradigms?
First-Line Treatment of Metastatic Melanoma After Adjuvant Anti-PD-1
First-Line Treatment of Metastatic Melanoma After Adjuvant Anti-PD-1
Navigating Treatment-Related Adverse Effects in LAG-3 Combination ICI Therapy for Metastatic Melanoma
Navigating Treatment-Related Adverse Effects in LAG-3 Combination ICI Therapy for Metastatic Melanoma
Patient Case: Tailoring First-Line Treatment for a Patient With Metastatic Melanoma and Impaired Performance Status
Patient Case: Tailoring First-Line Treatment for a Patient With Metastatic Melanoma and Impaired Performance Status
Managing Immunotherapy-Related Adverse Events during Adjuvant Treatment for Resectable Melanoma
Managing Immunotherapy-Related Adverse Events during Adjuvant Treatment for Resectable Melanoma
Case Consult: Adjuvant Therapy Following Localized Treatment for Stage III Melanoma
Case Consult: Adjuvant Therapy Following Localized Treatment for Stage III Melanoma
Navigating Adjuvant ICI Treatment in Stage II Melanoma: A Patient Case Presentation
Navigating Adjuvant ICI Treatment in Stage II Melanoma: A Patient Case Presentation
Analyzing Key Data from LAG-3 Combinations in the Treatment of Metastatic Melanoma
Analyzing Key Data from LAG-3 Combinations in the Treatment of Metastatic Melanoma
